Delhaize Group press release : Delhaize Group announces new

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Delhaize Group press release : Delhaize Group announces new General Counsel and Corporate Secretary

BRUSSELS, Belgium, March 5, 2015 (GLOBE NEWSWIRE) -- Delhaize Group is pleased to announce the appointment of Philippe Dechamps as General Counsel and Corporate Secretary for the Group effective today. 

"I am pleased to promote Philippe to this important position in our Group," said Frans Muller, Delhaize Group CEO. "Philippe brings multinational experience, a solid understanding of our business as well as sound legal judgment to help us achieve our objectives while continuing to promote a culture of integrity across the Group. I look forward to working with Philippe in his new role."

Philippe Dechamps joined Delhaize Group in 2008 and most recently held the role of Senior Vice President, General Counsel Europe & Asia. Prior to Delhaize Group, he started his legal career at Linklaters, and then led legal functions and directed legal strategy in various divisions of Solvay Group, Guidant Corporation and Abbott Laboratories.

Mr. Dechamps holds a Master of Laws degree from Harvard Law School.  He has also earned a Masters degree in European and International Laws from Vrije Universiteit Brussel Law School and a Law degree from Université Catholique de Louvain Law school.

» Delhaize Group

Delhaize Group is a Belgian international food retailer present in seven countries on three continents. At the end of 2014, Delhaize Group's sales network consisted of 3 402 stores. In 2014, Delhaize Group recorded €21.4 billion ($29.4 billion) in revenues and €89 million ($118 million) net profit (Group share). At the end of 2014, Delhaize Group employed approximately 150 000 people. Delhaize Group's stock is listed on NYSE Euronext Brussels (DELB) and the New York Stock Exchange (DEG).

This press release is available in English, French and Dutch. You can also find it on the website http://www.delhaizegroup.com . Questions can be sent to investor@delhaizegroup.com .

» Contacts

Investor Relations: +32 2 412 21 51
Media Relations: +32 2 412 86 69

cautionary note regarding forward looking statements

Statements that are included or incorporated by reference in this press release and other written and oral statements made from time to time by Delhaize Group and its representatives, other than statements of historical fact, which address activities, events and developments that Delhaize Group expects or anticipates will or may occur in the future, including, without limitation, changes in executive management and the anticipated benefits of these changes, are "forward-looking statements" within the meaning of the U.S. federal securities laws that are subject to risks and uncertainties. These forward-looking statements generally can be identified as statements that include phrases such as "guidance," "outlook," "projected," "believe," "target," "predict," "estimate," "forecast," "strategy," "may," "goal," "expect," "anticipate," "intend," "plan," "foresee," "likely," "will," "should" or other similar words or phrases. Although such statements are based on current information, actual outcomes and results may differ materially from those projected depending upon a variety of factors, including, but not limited to, changes in the general economy or the markets of Delhaize Group, in strategy, in consumer spending, in inflation or currency exchange rates or in legislation or regulation; competitive factors; adverse determination with respect to claims; inability to timely develop, remodel, integrate, open, convert or close stores; and supply or quality control problems with vendors. Additional risks and uncertainties that could cause actual results to differ materially from those stated or implied by such forward-looking statements are described in Delhaize Group's most recent Annual Report on Form 20-F and other filings made by Delhaize Group with the U.S. Securities and Exchange Commission, which risk factors are incorporated herein by reference. Delhaize Group disclaims any obligation to update developments of these risk factors or to announce publicly any revision to any of the forward-looking statements contained in this release, or to make corrections to reflect future events or developments.

Press release in pdf format http://hugin.info/133961/R/1899493/674837.pdf

HUG#1899493

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 3

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 1

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 5

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading
USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 7

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 3

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 5

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
OneOdio Showcases Innovation at IFA 2026 in Berlin

Updated Category News Views 5

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Continue Reading
Pizza: The Unlikely Symbol of Universal Togetherness

Updated Category News Views 6

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Continue Reading

Top 5 Most Recently Viewed Articles

Arch Capital Group Achieves $978 Million in Q3 Earnings

Updated Category News Views 135

Arch Capital Group Reports Third Quarter Financial Success Arch Capital Group Ltd. (NASDAQ: ACGL) recently announced strong financial results for the third quarter. This report signifies a remarkable achievement for the company as it reflects the overall financial health and operational efficiency across its diverse business segments. Strong Financial Performance The net...

Continue Reading
Unleashing Potential: BexBack's Innovative Crypto Trading

Updated Category News Views 131

Welcome to the New Era of Cryptocurrency Trading with BexBack The cryptocurrency market is known for its unpredictability, and with Bitcoin's price teetering around $100,000, many traders find themselves navigating a landscape filled with uncertainty. In such a turbulent environment, seasoned investors are increasingly turning to futures trading with 100x leverage to...

Continue Reading
MasHash Unveils Revolutionary Cloud Mining Platform

Updated Category News Views 292

MasHash Launches Innovative Cloud-Based Mining Platform MasHash, a prominent provider of cloud-based cryptocurrency mining solutions, has unveiled its latest and improved mining platform. This new offering aims to revolutionize how users participate in crypto mining and enhance their profitability. The Growing Significance of Crypto Mining in 2024 As we enter 2024, the...

Continue Reading
Syndax Pharmaceuticals Plans Engaging Investor Event Soon

Updated Category News Views 29

Investor Event Scheduled for December Syndax Pharmaceuticals (Nasdaq: SNDX), a pioneering biopharmaceutical company renowned for its cutting-edge cancer treatments, has announced an upcoming investor event. This event will allow attendees to engage directly with the Syndax team and learn more about the groundbreaking research being conducted in the field of oncology....

Continue Reading
Introducing Seguritech's Smartwatch for Safety and Health Monitoring

Updated Category News Views 178

Introducing Seguritech's Innovative Smartwatch Seguritech has taken a bold step in personal safety with the introduction of its Early Warning Smartwatch. This remarkable device connects users seamlessly to a network of Command and Control Centers, ensuring immediate access to emergency responders in critical situations. Key Features of the Early Warning Smartwatch The...

Continue Reading